The statistical assessment of the design, analysis and interpretation of studies and/or a package of studies can be critical as part of an in-licensing decision.

DaneStat can provide such a review to help you assess the risks or statistical issues in a program, or the additional work that may be required before a product is ready for progression into later phases of development or ready for regulatory submission.



DaneStat have over 10 years’ experience performing Due Diligence and in-licensing reviews, and reviewing Due Diligence reports from other team members.

DaneStat have also shared their experience and recommendations regarding due diligence in a presentation at a conference for statisticians within the Pharmaceutical industry (PSI).